Products

FETOLY-HEART
Diagnoly
OB/GYN AI
FETOLY-HEART by Diagnoly is an AI-powered real-time fetal ultrasound assistant that detects heart and brain anomalies, ensures exam completeness, and streamlines workflows by operating locally on mobile devices.
FETOLY
Diagnoly
OB/GYN AI
Fetoly by Diagnoly is an AI-powered real-time fetal ultrasound assistant that enhances prenatal screenings, standardizes exams, and aids in the detection of fetal heart and brain anomalies.

See all 2 products →

About Diagnoly

Diagnoly is a pioneering DeepTech company in the healthcare AI sector, dedicated to transforming obstetric ultrasound with real-time artificial intelligence. Their flagship software, Fetoly, functions as an AI-powered co-pilot for clinicians, enhancing fetal screenings by providing immediate analysis and insights directly during ultrasound examinations. This innovative approach aims to improve the accuracy and consistency of prenatal screening, significantly reducing the operator dependence often associated with complex ultrasound techniques.

The company’s technology is designed to detect fetal abnormalities, particularly focusing on congenital heart defects and cerebral conditions, which can often go undetected in traditional screenings. Fetoly operates locally on devices like iPads, seamlessly integrating with existing ultrasound systems via HDMI without requiring cloud services, thereby ensuring secure patient data management and minimal disruption to clinical workflows. Diagnoly’s solutions are geared towards improving maternal and fetal outcomes by enabling earlier detection of complications, standardizing scan quality, and reinforcing diagnostic confidence for healthcare professionals worldwide.

Focus Areas

Prenatal mother-fetal medicine women's health fetal ultrasound screening real-time AI-powered analysis for detection of fetal abnormalities (especially cardiac and cerebral conditions) improving accuracy and consistency of ultrasound examinations.

Business Intelligence

Key InvestorsMutuelles Impact, XAnge, Newfund, BADGE (Les Business Angels des Grandes Écoles), KOL physicians, WorldUpstart, Simba Santé 3
PartnershipsGE HealthCare
TechnologyCloud-native (on-device processing), edge computing (local processing without internet/cloud), AI operating system (proprietary computer science and deep learning algorithms for real-time analysis of ultrasound image streams)
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Core Specialization
Diagnoly focuses on Prenatal Mother-Fetal Medicine and Women's Health, offering advanced solutions for fetal ultrasound screening.
AI-Powered Analysis
They utilize real-time AI-powered analysis to detect fetal abnormalities, significantly enhancing diagnostic capabilities during examinations.
Key Anomaly Focus
A particular specialization lies in the detection of complex fetal conditions, especially cardiac and cerebral abnormalities, which are critical for early intervention.
Diagnostic Improvement
Diagnoly aims to improve the accuracy and consistency of fetal ultrasound examinations, reducing variability and enhancing diagnostic confidence.
Key Differentiators
Their real-time AI analysis for complex fetal conditions, combined with a focus on improving diagnostic consistency and accuracy, sets them apart from traditional methods.
Technology Stack (Inferred)
Leverages advanced Artificial Intelligence and Machine Learning algorithms for real-time image processing and pattern recognition, likely integrated with cloud-based infrastructure for scalability and data analysis.
Physician Tip

For physicians, Diagnoly offers a powerful tool to enhance diagnostic precision and efficiency in prenatal care. The real-time AI analysis can act as a 'second pair of eyes,' reducing the cognitive load and potential for human error, especially in detecting subtle cardiac and cerebral anomalies. This leads to more confident diagnoses, potentially earlier interventions, and improved patient outcomes. The consistency it brings to ultrasound examinations can also be invaluable for training and standardizing practices across different sonographers and clinics. Consider how this technology can streamline your workflow, provide objective data for patient discussions, and support complex case reviews.

Diagnoly's real-time AI analysis is designed to integrate seamlessly with existing ultrasound imaging systems, providing immediate feedback during examinations. Potential integrations could extend to Electronic Health Records (EHR) for automated documentation of findings, Picture Archiving and Communication Systems (PACS) for image storage and retrieval, and telemedicine platforms for remote consultation and expert review.

Products by Diagnoly

2 products in the directory

FETOLY-HEART
Diagnoly
OB/GYN AI
FETOLY-HEART by Diagnoly is an AI-powered real-time fetal ultrasound assistant that detects heart and brain anomalies, ensures exam completeness, and streamlines workflows by operating locally on mobile devices.
FETOLY
Diagnoly
OB/GYN AI
Fetoly by Diagnoly is an AI-powered real-time fetal ultrasound assistant that enhances prenatal screenings, standardizes exams, and aids in the detection of fetal heart and brain anomalies.

What the Web Says

Diagnoly is a DeepTech company specializing in real-time AI solutions for prenatal ultrasound screening, with its primary product being the Fetoly application. The company aims to improve screening quality, enhance consistency, and support the early detection of fetal abnormalities, addressing the issue of up to 50% of fetal abnormalities remaining undetected during pregnancy. Diagnoly's Fetoly application is FDA-cleared and CE-marked, operates locally on devices like iPads without cloud dependency, and integrates with most ultrasound systems, including GE HealthCare's Voluson. Reviews from clinicians highlight its effectiveness in providing faster and more accurate fetal assessments, aiding clinical decision-making, and ensuring exam completeness and quality.

Overall: Positive

Strengths

  • Significantly improves prenatal screening workflow with faster and more accurate fetal assessments.
  • Supports better clinical decision-making and increases confidence in identifying fetal abnormalities early.
  • Provides real-time feedback on anatomy and plane quality, and helps obtain correct views and immediate measurements.
  • Enhances exam completeness by analyzing over 100 fetal anatomical structures and landmarks.
  • Operates locally on devices (e.g., iPad) without requiring cloud or internet, ensuring patient data privacy.
  • Compatible with major ultrasound machines and integrates with existing workflows.

Limitations

  • No specific negative product reviews were found on the searched platforms (G2, Glassdoor, Capterra, Reddit).
  • No specific negative employer reviews were found on the searched platforms (G2, Glassdoor, Capterra, Reddit).

Based on reviews from: Diagnoly Website, GE HealthCare, AuntMinnie, ICE Magazine

Last updated: 2026-07-18

Videos

News, demos, and interviews about Diagnoly.

Loading videos...

Videos load interactively. If none appear, search YouTube for Diagnoly →

View all on YouTube

Press & Coverage

Diagnoly
Diagnoly introduces the Next Generation of Fetoly for AI-Assisted Fetal Ultrasound with Full Fetus Anatomy at the FMF World Congress 2026
Diagnoly will unveil the next generation of its Fetoly application at the FMF World Congress 2026, introducing Full Fetus Anatomy and a redesigned user experience to provide comprehensive real-time guidance across the complete fetal anatomy.
2026-06
Applied Radiology
Diagnoly Introduces Real-Time AI for Fetal Ultrasound on iOS
Diagnoly has launched its AI-powered application, Fetolyu2122, on iOS, expanding accessibility for prenatal care professionals globally and integrating advanced ultrasound AI into standard clinical practice.
2026-04
Diagnoly
Diagnoly Expands Access to Real-Time AI for Fetal Ultrasound Screening
Diagnoly continues its global expansion by launching Fetolyu2122 on iOS, making real-time AI assistance more accessible to prenatal care professionals worldwide and enhancing standardization and efficiency in fetal ultrasound examinations.
2026-04
Diagnostic Imaging Europe
Diagnoly Expands Fetal Ultrasound AI with iOS Launch
Diagnoly has announced the expansion of its fetal ultrasound AI platform Fetolyu2122, now available on iOS devices, enabling obstetricians, maternal-fetal medicine specialists, and sonographers to access real-time AI support directly on iPads.
2026-04
AuntMinnie
Diagnoly launches Fetoly fetal ultrasound AI app on iOS
Diagnoly has launched its AI-powered Fetoly fetal ultrasound application on iOS, which is already deployed in over 20 countries and follows a collaboration with GE HealthCare.
2026-04
GE HealthCare
GE HealthCare strengthens AI offerings with Diagnoly collaboration to advance AI-enabled fetal ultrasound
GE HealthCare announced a collaboration with Diagnoly to advance the use of artificial intelligence in fetal ultrasound assessments, integrating Diagnoly's Fetolyu2122 solution within GE HealthCare's Volusonu2122 women's health ultrasound systems.
2026-02
Medical-Devices.tech
AI-Assisted Fetal Ultrasound Integration by GE HealthCare and Diagnoly
GE HealthCare and Diagnoly are collaborating to integrate real-time artificial intelligence (AI) capabilities into GE HealthCare's Voluson family of women's health ultrasound systems to support clinicians with standardized exam completeness and anatomical assessment in obstetrics.
2026-02
XAnge
Diagnoly Raises u20ac5.5M to Reinvent Ultrasound Through AI
Diagnoly, a DeepTech company specializing in AI-driven prenatal screening, announced its u20ac5.5M Seed funding round, led by Mutuelles Impact (managed by XAnge) and Newfund, to accelerate technological development and expand globally.
2025-04

Frequently Asked Questions

Diagnoly's AI leverages advanced algorithms trained on vast datasets of fetal ultrasound images to provide real-time analysis, highlighting subtle anomalies in cardiac and cerebral structures. This augments the sonographer's capabilities, leading to earlier and more accurate identification of potential conditions.
Diagnoly's AI provides standardized protocols and real-time guidance during scans, minimizing inter-operator variability and ensuring consistent image acquisition. The system offers objective measurements and interpretations, reducing subjective bias and improving diagnostic reliability across the healthcare network.
Diagnoly is committed to stringent regulatory compliance and has obtained necessary clearances, such as FDA approval and CE Mark certification, for its core AI-powered fetal analysis platforms. These certifications validate the safety and efficacy of our technology for clinical use.
Diagnoly's platform is designed for seamless integration with most modern ultrasound machines via standard DICOM protocols, allowing for direct image transfer and analysis. It also offers flexible API options for integration with various Electronic Medical Record (EMR) systems, streamlining data flow and reporting within existing clinical workflows.
Diagnoly offers flexible pricing models, including subscription-based licensing and per-study fees, tailored to the volume and needs of individual clinics or hospital systems. Healthcare providers typically see a strong ROI through improved diagnostic accuracy, reduced need for repeat scans, and enhanced patient outcomes.
Diagnoly provides comprehensive onboarding training for physicians and sonographers, covering system operation, AI interpretation, and best practices for integrating the technology into clinical workflows. We also offer continuous technical support, regular software updates, and educational resources to ensure optimal utilization and performance.
Diagnoly actively collaborates with prominent academic medical centers for research and validation, and we are pursuing strategic partnerships with major ultrasound equipment manufacturers to enhance integration and market reach. Our long-term vision is to be the leading AI platform for prenatal diagnostics, continuously expanding our capabilities to cover a broader spectrum of women's health conditions.
Diagnoly is a well-funded and rapidly growing company with a strong track record of innovation and successful deployments in the healthcare AI sector. We are backed by reputable investors and have a dedicated team of experts in AI, medical imaging, and women's health, ensuring long-term stability and continuous product development.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.